Literature DB >> 32469801

Contacts with Health Services During the Year Prior to Suicide Death and Prevalent Conditions A Nationwide Study.

Moussa Laanani1, Claire Imbaud2, Philippe Tuppin3, Claire Poulalhon4, Fabrice Jollant5, Joël Coste6, Grégoire Rey2.   

Abstract

BACKGROUND: This study was designed to describe contacts with health services during the year before suicide death in France, and prevalent mental and physical conditions.
METHODS: Data were extracted from the French National Health Data System (SNDS), which comprises comprehensive claims data for inpatient and outpatient care linked to the national causes-of-death registry. Individuals aged ≥15 years who died from suicide in France in 2013-2015 were included. Medical consultations, emergency room visits, and hospitalisations during the year preceding death were collected. Conditions were identified, and standardised prevalence ratios (SPRs) were estimated to compare prevalence rates in suicide decedents with those of the general population.
RESULTS: The study included 19,144 individuals. Overall, 8.5% of suicide decedents consulted a physician or attended an emergency room on the day of death, 34.1% during the week before death, 60.9% during the month before death. Most contacts involved a general practitioner or an emergency room. During the month preceding suicide, 24.4% of individuals were hospitalised at least once. Mental conditions (36.8% of cases) were 7.9-fold more prevalent in suicide decedents than in the general population. The highest SPRs among physical conditions were for liver/pancreatic diseases (SPR=3.3) and epilepsy (SPR=2.7). LIMITATIONS: The study population was restricted to national health insurance general scheme beneficiaries (76% of the population living in France).
CONCLUSIONS: Suicide decedents have frequent contacts with general practitioners and emergency departments during the last weeks before death. Improving suicide risk identification and prevention in these somatic healthcare settings is needed.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Health Services; Mental Disorders; Somatic Disorders; Suicide; Utilisation

Mesh:

Year:  2020        PMID: 32469801     DOI: 10.1016/j.jad.2020.05.071

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Healthcare utilization and comorbidity shortly before suicide mortality in patients with attention-deficit/hyperactivity disorder: a nested case-control study.

Authors:  Wan-Chen Lee; Chun-Hung Pan; Sheng-Siang Su; Shang-Ying Tsai; Chiao-Chicy Chen; Chian-Jue Kuo
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-07-03       Impact factor: 4.785

Review 2.  Suicide and Epilepsy.

Authors:  Luciana Giambarberi; Heidi M Munger Clary
Journal:  Curr Neurol Neurosci Rep       Date:  2022-06-17       Impact factor: 6.030

3.  Prospective Validation of an Electronic Health Record-Based, Real-Time Suicide Risk Model.

Authors:  Colin G Walsh; Kevin B Johnson; Michael Ripperger; Sarah Sperry; Joyce Harris; Nathaniel Clark; Elliot Fielstein; Laurie Novak; Katelyn Robinson; William W Stead
Journal:  JAMA Netw Open       Date:  2021-03-01

4.  Suicide preceded by health services contact - A whole-of-population study in New Zealand 2013-2015.

Authors:  Annie Chiang; Janine Paynter; Richard Edlin; Daniel J Exeter
Journal:  PLoS One       Date:  2021-12-20       Impact factor: 3.240

5.  Suicide Screening Tools for Pediatric Emergency Department Patients: A Systematic Review.

Authors:  Amanda Scudder; Richard Rosin; Becky Baltich Nelson; Edwin D Boudreaux; Celine Larkin
Journal:  Front Psychiatry       Date:  2022-07-12       Impact factor: 5.435

6.  Health care utilization among individuals who die by suicide as compared to the general population: a population-based register study in Sweden.

Authors:  Elisabeth Bondesson; Tori Alpar; Ingemar F Petersson; Maria E C Schelin; Anna Jöud
Journal:  BMC Public Health       Date:  2022-08-25       Impact factor: 4.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.